Global Medicines Development

GMD transforms molecules into medicines that change lives. Our medical, clinical and scientific experts generate data to get new medicines approved and evidence to show their true value.

~5,000

GMD employees

~100,000

Patients in clinical trials each year

15

Medicines in late-stage development (June 2015)

~300

Publications from GMD scientists each year

Our GMD capabilities

GMD has deep disease area, scientific and medical knowledge – connecting our science to the needs of physicians, healthcare professionals and patients to help deliver better, safer, more effective medicines.

A global reach

There are around 5,000 people in GMD. Our critical, core drug development expertise is at the heart of our three vibrant scientific centres in Gothenburg (Sweden), Cambridge (UK) and Gaithersburg (US). GMD scientists are located in other research locations, supporting important clinical development and pharmaceutical development activities along with clinical trial site management and monitoring in around 40 countries.

Working in partnership

To push the boundaries of science to deliver life-changing medicines we continually seek out opportunities to combine our scientific experience and insights with that of other leading institutions around the world.